Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$90.94 - $199.54 $177,605 - $389,701
-1,953 Closed
0 $0
Q2 2023

Aug 09, 2023

SELL
$155.98 - $172.65 $13,102 - $14,502
-84 Reduced 4.12%
1,953 $316,000
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $18,924 - $22,757
-143 Reduced 6.56%
2,037 $324,000
Q4 2022

Feb 09, 2023

SELL
$102.55 - $135.33 $77,117 - $101,768
-752 Reduced 25.65%
2,180 $295,000
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $89,753 - $110,148
-942 Reduced 24.32%
2,932 $292,000
Q2 2022

Aug 09, 2022

SELL
$103.24 - $121.81 $74,229 - $87,581
-719 Reduced 15.65%
3,874 $432,000
Q1 2022

May 16, 2022

SELL
$93.1 - $112.54 $26,068 - $31,511
-280 Reduced 5.75%
4,593 $510,000
Q4 2021

Feb 11, 2022

BUY
$95.88 - $117.08 $93,578 - $114,270
976 Added 25.04%
4,873 $546,000
Q3 2021

Nov 12, 2021

SELL
$84.42 - $106.62 $29,631 - $37,423
-351 Reduced 8.26%
3,897 $271,000
Q2 2021

Aug 16, 2021

BUY
$67.66 - $84.76 $17,050 - $21,359
252 Added 6.31%
4,248 $356,000
Q4 2020

Feb 10, 2021

BUY
$63.89 - $73.8 $6,325 - $7,306
99 Added 2.54%
3,996 $279,000
Q3 2020

Nov 13, 2020

BUY
$63.69 - $70.22 $22,737 - $25,068
357 Added 10.08%
3,897 $271,000
Q2 2020

Aug 14, 2020

BUY
$58.54 - $67.94 $14,400 - $16,713
246 Added 7.47%
3,540 $232,000
Q1 2020

May 13, 2020

BUY
$49.46 - $64.78 $1,780 - $2,332
36 Added 1.1%
3,294 $198,000
Q4 2019

Feb 07, 2020

BUY
$49.86 - $58.26 $65,117 - $76,087
1,306 Added 66.91%
3,258 $189,000
Q3 2019

Nov 07, 2019

BUY
$47.54 - $53.43 $69,028 - $77,580
1,452 Added 290.4%
1,952 $101,000
Q2 2019

Aug 13, 2019

BUY
$46.79 - $52.47 $20,961 - $23,506
448 Added 861.54%
500 $26,000
Q1 2019

May 15, 2019

BUY
$46.36 - $52.63 $463 - $526
10 Added 23.81%
52 $3,000
Q4 2018

Feb 13, 2019

BUY
$41.54 - $47.25 $789 - $897
19 Added 82.61%
42 $2,000
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $1,075 - $1,178
23 New
23 $1,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Td Ameritrade Investment Management, LLC Portfolio

Follow Td Ameritrade Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Ameritrade Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Ameritrade Investment Management, LLC with notifications on news.